BeiGene Ltd. (49B) — Capital Reinvestment Ratio
Latest as of March 2025:
2.64x
BeiGene Ltd. (49B) has a Capital Reinvestment Ratio of 2.64x as of March 2025, meaning it reinvests 3% of its operating cash flow (€44.08 Million) in capital expenditures (€116.41 Million). See free cash flow generation of BeiGene Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.64x
Capex / Operating Cash Flow
Operating Cash Flow
€44.08 Million
EUR
Capital Expenditures
€116.41 Million
EUR
Data as of
Mar 2025
Most recent filing
BeiGene Ltd. Capital Reinvestment Ratio (2017–2017)
This chart tracks BeiGene Ltd.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for BeiGene Ltd. (2017–2017)
Year-by-year Capital Reinvestment Ratio for BeiGene Ltd. from 2017 to 2017. For live market cap and broader valuation context, see 49B market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 3.64x | €12.75 Million | €46.37 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow